T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SFS
1276
DELISTED
Smart & Final Stores, Inc.
SFS
| $11.4M | ﹤0.01% |
+722,930
| New | +$12.1M |
|
|
POLY
1277
DELISTED
Plantronics, Inc.
POLY
| $11.3M | ﹤0.01% |
222,750
+14,300
| +7% | +$781K |
|
1278
Nasdaq
NDAQ
$54.6B
| $11.3M | ﹤0.01% |
634,770
| – | – |
|
1279
Fluor
FLR
$7B
| $11.2M | ﹤0.01% |
265,064
-13,210
| -5% | -$620K |
|
1280
Donaldson
DCI
$11.1B
| $11.2M | ﹤0.01% |
399,142
+14,500
| +4% | +$466K |
|
|
SMRT
1281
DELISTED
Stein Mart Inc
SMRT
| $11.2M | ﹤0.01% |
1,157,766
-547,533
| -32% | -$5.64M |
|
1282
Service Corp International
SCI
$11.3B
| $11.2M | ﹤0.01% |
413,131
+353,300
| +590% | +$10.4M |
|
|
OXFD
1283
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $11.2M | ﹤0.01% |
829,246
-30,654
| -4% | -$416K |
|
|
AIMT
1284
DELISTED
Aimmune Therapeutics
AIMT
| $11.2M | ﹤0.01% |
+441,638
| New | +$10.3M |
|
|
AIV
1285
Aimco
AIV
$379M
| $11.1M | ﹤0.01% |
2,242,110
+79,647
| +4% | +$403K |
|
|
NTUS
1286
DELISTED
Natus Medical Inc
NTUS
| $11M | ﹤0.01% |
278,500
+93,700
| +51% | +$3.98M |
|
|
XRM
1287
DELISTED
Xerium Technologies Inc (new)
XRM
| $10.9M | ﹤0.01% |
835,954
+135,400
| +19% | +$2.02M |
|
1288
FMC
FMC
$1.27B
| $10.6M | ﹤0.01% |
361,687
-19,716
| -5% | -$764K |
|
|
BPMC
1289
DELISTED
Blueprint Medicines
BPMC
| $10.6M | ﹤0.01% |
498,149
-5,401
| -1% | -$149K |
|
1290
United Rentals
URI
$69.7B
| $10.6M | ﹤0.01% |
176,760
+3,700
| +2% | +$257K |
|
1291
Phibro Animal Health
PAHC
$1.38B
| $10.4M | ﹤0.01% |
328,200
+75,000
| +30% | +$2.74M |
|
|
SEMG
1292
DELISTED
SEMGROUP CORPORATION
SEMG
| $10.4M | ﹤0.01% |
239,900
-1,900
| -0.8% | -$115K |
|
1293
Pegasystems
PEGA
$5.51B
| $10.4M | ﹤0.01% |
842,800
+60,400
| +8% | +$747K |
|
1294
Leggett & Platt
LEG
$1.32B
| $10.4M | ﹤0.01% |
251,246
+1,400
| +0.6% | +$65.4K |
|
|
AXE
1295
DELISTED
Anixter International Inc
AXE
| $10.3M | ﹤0.01% |
179,000
-8,000
| -4% | -$501K |
|
1296
Assurant
AIZ
$13.9B
| $10.3M | ﹤0.01% |
130,855
-1,190
| -0.9% | -$88.8K |
|
|
HZNP
1297
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $10.3M | ﹤0.01% |
518,902
-497,487
| -49% | -$15.7M |
|
1298
US Physical Therapy
USPH
$1.24B
| $10.2M | ﹤0.01% |
228,300
+90,500
| +66% | +$4.51M |
|
|
STMP
1299
DELISTED
Stamps.com, Inc.
STMP
| $10.2M | ﹤0.01% |
138,300
+31,400
| +29% | +$2.44M |
|
|
CRZO
1300
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $10.1M | ﹤0.01% |
332,200
+16,700
| +5% | +$605K |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.